Literature DB >> 2302116

Polytef (polytetrafluoroethylene) alloplastic grafting as a substitute for mucous membrane.

P S Levin1, J J Dutton.   

Abstract

Nine patients with contracted sockets, cicatricial conjunctival shortening, or severe symblepharon formation were treated by temporary grafting with polytef (polytetrafluoroethylene) alloplastic surgical membrane in place of autogenous mucous membrane. Within 2 weeks of the grafting, the patients' residual conjunctival epithelium grew beneath the alloplastic membrane and covered the raw surfaces of the reconstructed socket. The procedure produced satisfactory results in eight of nine patients without the need for harvesting mucous membrane from the mouth or nose. Healing was rapid and without the discomfort and potential complications associated with grafting of autogenous mucosa.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302116     DOI: 10.1001/archopht.1990.01070040134047

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Cultured corneal epithelia for ocular surface disease.

Authors:  I R Schwab
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  Rigid nylon foil-anchored polytetrafluoroetyhlene (Gore-Tex) sheet stenting for conjunctival fornix reconstruction.

Authors:  Hakan Demirci; Susan G Elner; Victor M Elner
Journal:  Ophthalmology       Date:  2010-08-05       Impact factor: 12.079

3.  The reconstruction of a contracted eye socket using a post-auricular full-thickness skin graft.

Authors:  Yi Hsuan Wei; Shu Lang Liao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-06       Impact factor: 3.117

4.  Surgical management of ocular surface disorders using conjunctival and stem cell allografts.

Authors:  D J Coster; R K Aggarwal; K A Williams
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

5.  Management of complicated multirecurrent pterygia using multimicroporous expanded polytetrafluoroethylene.

Authors:  Kyoung Woo Kim; Jae Chan Kim; Jun Hyung Moon; Hyun Koo; Tae Hyung Kim; Nam Ju Moon
Journal:  Br J Ophthalmol       Date:  2013-03-15       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.